Gérard Foucher (Docteur de 3e cycle Paris-IV, professeur agrégé d’anglais) , François Pillon (Docteur en pharmacie et en médecine)
{"title":"What’s breastfeeding?","authors":"Gérard Foucher (Docteur de 3e cycle Paris-IV, professeur agrégé d’anglais) , François Pillon (Docteur en pharmacie et en médecine)","doi":"10.1016/j.actpha.2024.06.015","DOIUrl":"10.1016/j.actpha.2024.06.015","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 638","pages":"Pages 59-60"},"PeriodicalIF":0.1,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141963718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jean-Michel Mrozovski (Président du Comité pour la valorisation de l’acte officinal (CVAO))
{"title":"Comprendre l’hésitation vaccinale","authors":"Jean-Michel Mrozovski (Président du Comité pour la valorisation de l’acte officinal (CVAO))","doi":"10.1016/j.actpha.2024.06.014","DOIUrl":"10.1016/j.actpha.2024.06.014","url":null,"abstract":"<div><p>Depuis le 8 août 2023, le pharmacien est devenu autonome dans son acte vaccinal. Il peut prescrire et administrer tous les vaccins recommandés dans le calendrier des vaccinations aux personnes de 11 ans et plus, en dehors des vaccins vivants atténués pour les patients immunodéprimés. Il est dès lors encore plus qu’auparavant confronté à l’hésitation vaccinale.</p></div><div><p>Since 8 August 2023, pharmacists have been autonomous when it comes to vaccinations. They can prescribe and administer all the vaccines recommended in the vaccination calendar to people aged 11 and over, with the exception of live attenuated vaccines for immunocompromised patients. This means that, even more than before, they are faced with the problem of vaccine hesitancy.</p></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 638","pages":"Pages 54-57"},"PeriodicalIF":0.1,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141963717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yves Michiels (Docteur en pharmacie) , Jean-Paul Belon (Professeur émérite en pharmacologie, médecin, pharmacien)
{"title":"Covid long, des symptômes aux hypothèses moléculaires","authors":"Yves Michiels (Docteur en pharmacie) , Jean-Paul Belon (Professeur émérite en pharmacologie, médecin, pharmacien)","doi":"10.1016/j.actpha.2024.06.012","DOIUrl":"10.1016/j.actpha.2024.06.012","url":null,"abstract":"<div><p>Les patients qui ont contracté le Sars-CoV-2 n’en ressentent généralement les manifestations que sur une courte période, mais certains présentent des symptômes prolongés pendant plusieurs semaines à plusieurs mois. Ces malades sont atteints d’un syndrome dit du Covid long qui impacte leur vie au quotidien de manière durable. De nombreux mécanismes moléculaires commencent à être mis au jour pour expliquer ce phénomène. Les professionnels de santé doivent maîtriser ces nouvelles connaissances afin d’offrir une prise en charge médicale optimale.</p></div><div><p>Patients who have contracted Sars-CoV-2 usually experience symptoms for only a short time, but some experience prolonged symptoms lasting from several weeks to several months. These patients suffer from a syndrome known as “long Covid”, which has a lasting impact on their daily lives. Numerous molecular mechanisms are beginning to be uncovered to explain this phenomenon. Healthcare professionals need to master this new knowledge in order to offer optimal medical care.</p></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 638","pages":"Pages 45-48"},"PeriodicalIF":0.1,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141953752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"L’activité physique et sportive, enjeu de santé publique","authors":"Peggy André (Docteure en pharmacie)","doi":"10.1016/j.actpha.2024.06.013","DOIUrl":"10.1016/j.actpha.2024.06.013","url":null,"abstract":"<div><p>En cette année olympique, chacun, quels que soient son âge et son état physique, est encouragé à pratiquer 30 minutes d’activité physique ou sportive chaque jour et, en parallèle, à limiter ses périodes de sédentarité. L’objectif est d’améliorer le bien-être de tous et de lutter contre les maladies liées à l’inactivité.</p></div><div><p>In this Olympic year, everyone, whatever their age or physical condition, is encouraged to take part in 30<!--> <!-->minutes of physical activity or sport every day, and at the same time to limit periods of inactivity. The aim is to improve everyone’s well-being and combat illnesses linked to inactivity.</p></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 638","pages":"Pages 49-53"},"PeriodicalIF":0.1,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141953753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Évaluez-vous !","authors":"Élisa Derrien (Rédactrice en chef)","doi":"10.1016/j.actpha.2024.06.016","DOIUrl":"10.1016/j.actpha.2024.06.016","url":null,"abstract":"<div><p>Ce QCM vous permet de vérifier les connaissances acquises à la lecture du numéro d’<em>Actualités pharmaceutiques</em>.</p></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 638","pages":"Pages 62-64"},"PeriodicalIF":0.1,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141963719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sandra Mazet (Docteur en pharmacie), Alexis Desmoulière (Professeur des universités)
{"title":"Mieux connaître la mucoviscidose","authors":"Sandra Mazet (Docteur en pharmacie), Alexis Desmoulière (Professeur des universités)","doi":"10.1016/j.actpha.2024.06.005","DOIUrl":"10.1016/j.actpha.2024.06.005","url":null,"abstract":"<div><p>La mucoviscidose est une pathologie largement répandue dans le monde entier et la maladie génétique héréditaire rare la plus fréquente dans les populations occidentales. De nombreux organes sont touchés chez les patients atteints. Les lésions sont liées à la dysfonction d’un canal ionique, la protéine CFTR, dont la synthèse peut être altérée par différents types de mutations. L’officinal doit être à même de renseigner son patient et ses proches sur cette maladie.</p></div><div><p>Cystic fibrosis is a widespread disease worldwide, and the most common rare hereditary genetic disorder in Western populations. Many organs are affected in cystic fibrosis patients. Lesions are linked to dysfunction of an ion channel, the CFTR protein, whose synthesis can be altered by various types of mutation. Pharmacists must be able to inform patients and their families about this disease.</p></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 638","pages":"Pages 17-21"},"PeriodicalIF":0.1,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141963727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jacques Buxeraud (Professeur des universités) , Sébastien Faure (Professeur des universités)
{"title":"Le ruxolitinib (Opzelura®), une crème pour repigmenter le vitiligo","authors":"Jacques Buxeraud (Professeur des universités) , Sébastien Faure (Professeur des universités)","doi":"10.1016/j.actpha.2024.06.002","DOIUrl":"10.1016/j.actpha.2024.06.002","url":null,"abstract":"<div><p>Le ruxolitinib, principe actif déjà connu comme antinéoplasique inhibiteur des Janus kinases (JAK), peut dorénavant être utilisé en crème dermique sous le nom de spécialité Opzelura® pour traiter le vitiligo. Il s’agit du premier inhibiteur de JAK, sous forme topique, à disposer d’une autorisation de mise sur le marché dans cette indication. À ce jour, aucun autre traitement n’est indiqué dans ce cadre.</p></div><div><p>Ruxolitinib, an active ingredient already known as an antineoplastic Janus kinase (JAK) inhibitor, can now be used as a dermal cream under the Opzelura® specialty name to treat vitiligo. This is the first topical JAK inhibitor to receive marketing authorization for this indication. To date, no other treatment is indicated for this condition.</p></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 638","pages":"Pages 9-11"},"PeriodicalIF":0.1,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141963724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Catherine Combescot (Docteur ès sciences université Montpellier II, parasitologue) , Arthur Piraux (Docteur en pharmacie)
{"title":"Lutter contre les poux, c’est possible","authors":"Catherine Combescot (Docteur ès sciences université Montpellier II, parasitologue) , Arthur Piraux (Docteur en pharmacie)","doi":"10.1016/j.actpha.2024.06.021","DOIUrl":"10.1016/j.actpha.2024.06.021","url":null,"abstract":"<div><p>Une infestation par les poux est généralement vécue comme un véritable fléau par les familles, prêtes à tout pour s’en débarrasser. Entre les remèdes de grand-mères et les produits chimiques, les conseils de l’équipe officinale, qui connaît parfaitement le cycle de reproduction de ces parasites, permettent de les éradiquer plus facilement.</p></div><div><p>An infestation of lice is generally experienced as a real scourge by families, who are ready to do anything to get rid of them. Between old-fashioned remedies and chemical products, advice from the pharmacy team, who know the reproduction cycle of these parasites inside out, makes it easier to eradicate them.</p></div>","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 638","pages":"Pages 15-17"},"PeriodicalIF":0.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Dispensation d’antibiotiques : la promotion du bon usage est indispensable","authors":"Jacques Buxeraud (Professeur des universités)","doi":"10.1016/j.actpha.2024.06.017","DOIUrl":"10.1016/j.actpha.2024.06.017","url":null,"abstract":"","PeriodicalId":41434,"journal":{"name":"Actualites Pharmaceutiques","volume":"63 638","pages":"Page 1"},"PeriodicalIF":0.1,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141951990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
